BJP Handbook for Psychiatric Trainees
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BROWN, S.
Right arrow Articles by INSKIP, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BROWN, S.
Right arrow Articles by INSKIP, H.
The British Journal of Psychiatry (2000) 177: 212-217
© 2000 The Royal College of Psychiatrists

Causes of the excess mortality of schizophrenia

STEVE BROWN, MRCPsych and BRIAN BARRACLOUGH, DM

Mental Health Group, University of Southampton

HAZEL INSKIP, PhD

Medical Research Council Environmental Epidemiology Unit, University of Southampton

Correspondence: Dr Steve Brown, Mental Health Group, University of Southampton, Royal South Hants Hospital, Brinton's Terrace, Southampton SO14 0YG, UK. Fax: 023 80234243; e-mail: sb15{at}soton.ac.uk

Declaration of interest Funded by the NHS Executive South and West Region, R & D Directorate. No conflict of interest.

1 One woman aged 66 was inadvertently included.

Background The excess mortality of schizophrenia is well recognised, but its precise causes are not well understood.

Aims To measure the standardised mortality ratio (SMR) and examine the reasons for any excess mortality in a community cohort with schizophrenia.

Method We carried out a 13-year follow-up of 370 patients with schizophrenia, identifying those who died and their circumstances.

Results Ninety-six per cent of the cohort was traced. There were 79 deaths. The SMRs for all causes (298), for natural (232) and for unnatural causes (1273), were significantly higher than those to be expected in the general population, as were the SMRs for disease of the circulatory, digestive, endocrine, nervous and respiratory systems, suicide and undetermined death. Smoking-related fatal disease was more prominent than in the general population.

Conclusions Some of the excess mortality of schizophrenia could be lessened by reducing patients'smoking and exposure to other environmental risk factors and by improving the management of medical disease, mood disturbance and psychosis.




This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
D. W. Bradford, M. M. Kim, L. E. Braxton, C. E. Marx, M. Butterfield, and E. B. Elbogen
Access to Medical Care Among Persons With Psychotic and Major Affective Disorders
Psychiatr Serv, August 1, 2008; 59(8): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
I. V. Vahia, S. Diwan, A. O. Bankole, M. Kehn, M. Nurhussein, P. Ramirez, and C. I. Cohen
Adequacy of Medical Treatment Among Older Persons With Schizophrenia
Psychiatr Serv, August 1, 2008; 59(8): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
Clinical Case StudiesHome page
T. V. Cooper, B. S. Hanson, R. S. Burke, and Y. M. Hunt
Sequential Treatment for Nicotine Dependence and Postcessation Weight Concern in a Female Diagnosed with Paranoid Schizophrenia
Clinical Case Studies, August 1, 2008; 7(4): 340 - 355.
[Abstract] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
J. Campion, K. Checinski, and J. Nurse
Review of smoking cessation treatments for people with mental illness
Advan. Psychiatr. Treat., May 1, 2008; 14(3): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
J. Campion, K. Checinski, J. Nurse, and A. McNeill
Smoking by people with mental illness and benefits of smoke-free mental health services
Advan. Psychiatr. Treat., May 1, 2008; 14(3): 217 - 228.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
M. Phelan and G. Blair
Medical history-taking in psychiatry
Advan. Psychiatr. Treat., May 1, 2008; 14(3): 229 - 234.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
R. C Peveler, D. Branford, L. Citrome, P. Fitzgerald, P. W Harvey, R. I. Holt, L. Howard, D. Kohen, I. Jones, V. O'Keane, et al.
Antipsychotics and hyperprolactinaemia: Clinical recommendations
J Psychopharmacol, March 1, 2008; 22(2_suppl): 98 - 103.
[PDF]


Home page
J PsychopharmacolHome page
K. Ojala, E. Repo-Tiihonen, J. Tiihonen, and L. Niskanen
Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents
J Psychopharmacol, January 1, 2008; 22(1): 33 - 38.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. Hippisley-Cox, Y. Vinogradova, C. Coupland, and C. Parker
Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder: Nested Case-Control Study
Arch Gen Psychiatry, December 1, 2007; 64(12): 1368 - 1376.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. Saha, D. Chant, and J. McGrath
A Systematic Review of Mortality in Schizophrenia: Is the Differential Mortality Gap Worsening Over Time?
Arch Gen Psychiatry, October 1, 2007; 64(10): 1123 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
I. Kooyman, K. Dean, S. Harvey, and E. Walsh
Outcomes of public concern in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s29 - s36.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. Kisely, M. Smith, D. Lawrence, M. Cox, L. A. Campbell, and S. Maaten
Inequitable access for mentally ill patients to some medically necessary procedures
Can. Med. Assoc. J., March 13, 2007; 176(6): 779 - 784.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K.-J. Bar, M. K. Boettger, S. Berger, V. Baier, H. Sauer, V. K. Yeragani, and A. Voss
Decreased baroreflex sensitivity in acute schizophrenia
J Appl Physiol, March 1, 2007; 102(3): 1051 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. M. Williams and J. Foulds
Successful Tobacco Dependence Treatment in Schizophrenia
Am J Psychiatry, February 1, 2007; 164(2): 222 - 227.
[Full Text] [PDF]


Home page
PsychosomaticsHome page
R. A. Bermudes, P. E. Keck Jr., and J. A. Welge
The Prevalence of the Metabolic Syndrome in Psychiatric Inpatients With Primary Psychotic and Mood Disorders
Psychosomatics, December 1, 2006; 47(6): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
C. P. Carney and L. E. Jones
Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.
Psychosom Med, September 1, 2006; 68(5): 684 - 691.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
A. P. Weiss, D. C. Henderson, J. B. Weilburg, D. C. Goff, J. B. Meigs, E. Cagliero, and R. W. Grant
Treatment of Cardiac Risk Factors Among Patients With Schizophrenia and Diabetes
Psychiatr Serv, August 1, 2006; 57(8): 1145 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
U. Werneke, O. Horn, A. Maryon-Davis, S. Wessely, S. Donnan, and K. McPherson
Uptake of screening for breast cancer in patients with mental health problems.
J. Epidemiol. Community Health, July 1, 2006; 60(7): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. Remington
Schizophrenia, Antipsychotics, and the Metabolic Syndrome: Is There a Silver Lining?
Am J Psychiatry, July 1, 2006; 163(7): 1132 - 1134.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. M. Harkavy-Friedman
Can Early Detection of Psychosis Prevent Suicidal Behavior?
Am J Psychiatry, May 1, 2006; 163(5): 768 - 770.
[Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
L. Chafetz, M. C. White, G. Collins-Bride, J. Nickens, and B. A. Cooper
Predictors of Physical Functioning Among Adults With Severe Mental Illness
Psychiatr Serv, February 1, 2006; 57(2): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. JOUKAMAA, M. HELIOVAARA, P. KNEKT, A. AROMAA, R. RAITASALO, and V. LEHTINEN
Schizophrenia, neuroleptic medication and mortality
The British Journal of Psychiatry, February 1, 2006; 188(2): 122 - 127.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
J. L. Micca, V. P. Hoffmann, I. Lipkovich, J. Ahl, R. W. Baker, and T. A. Hardy
Retrospective Analysis of Diabetes Risk in Elderly Patients With Dementia in Olanzapine Clinical Trials
Am J Geriatr Psychiatry, January 1, 2006; 14(1): 62 - 70.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
M. D. Llorente and V. Urrutia
Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications
Clin. Diabetes, January 1, 2006; 24(1): 18 - 24.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
N. Abdelmawla and A. J. Mitchell
Sudden cardiac death and antipsychotics. Part 1: Risk factors and mechanisms
Advan. Psychiatr. Treat., January 1, 2006; 12(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
S. Kisely, M. Smith, D. Lawrence, and S. Maaten
Mortality in individuals who have had psychiatric treatment: Population-based study in Nova Scotia
The British Journal of Psychiatry, December 1, 2005; 187(6): 552 - 558.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
S. Dursun, T. G. Dinan, C. Bushe, and J. Thakore
Challenges in advancing mental and physical health of patients with serious mental illness
J Psychopharmacol, November 1, 2005; 19(6_suppl): 3 - 5.
[PDF]


Home page
J PsychopharmacolHome page
C. Bushe, P. Haddad, R. Peveler, and J. Pendlebury
The role of lifestyle interventions and weight management in schizophrenia
J Psychopharmacol, November 1, 2005; 19(6_suppl): 28 - 35.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
L. Citrome
Metabolic Syndrome and Cardiovascular Disease
J Psychopharmacol, November 1, 2005; 19(6_suppl): 84 - 93.
[Abstract] [PDF]


Home page
Br. J. PsychiatryHome page
G. REMINGTON
Rational pharmacotherapy in early psychosis
The British Journal of Psychiatry, August 1, 2005; 187(48): s77 - s84.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. E. Foti, S. J. Bartels, M. P. Merriman, K. E. Fletcher, and A. D. Van Citters
Medical Advance Care Planning for Persons With Serious Mental Illness
Psychiatr Serv, May 1, 2005; 56(5): 576 - 584.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. E. Foti, S. J. Bartels, A. D. Van Citters, M. P. Merriman, and K. E. Fletcher
End-of-Life Treatment Preferences of Persons With Serious Mental Illness
Psychiatr Serv, May 1, 2005; 56(5): 585 - 591.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. FOULDS and J. WILLIAMS
Tobacco Use and Cataracts in Patients With Schizophrenia
Am J Psychiatry, May 1, 2005; 162(5): 1028 - 1028.
[Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
C. R. Richardson, G. Faulkner, J. McDevitt, G. S. Skrinar, D. S. Hutchinson, and J. D. Piette
Integrating Physical Activity Into Mental Health Services for Persons With Serious Mental Illness
Psychiatr Serv, March 1, 2005; 56(3): 324 - 331.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Bull.Home page
I. Cormac, M. Ferriter, R. Benning, and C. Saul
Physical health and health risk factors in a population of long-stay psychiatric patients
Psychiatr. Bull., January 1, 2005; 29(1): 18 - 20.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. M. Simpson, I. D. Glick, P. J. Weiden, S. J. Romano, and C. O. Siu
Randomized, Controlled, Double-Blind Multicenter Comparison of the Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients With Schizophrenia or Schizoaffective Disorder
Am J Psychiatry, October 1, 2004; 161(10): 1837 - 1847.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. Shiers and H. Lester
Early intervention for first episode psychosis
BMJ, June 19, 2004; 328(7454): 1451 - 1452.
[Full Text] [PDF]


Home page
Tobacco ControlHome page
M L Steinberg, J M Williams, and D M Ziedonis
Financial implications of cigarette smoking among individuals with schizophrenia
Tob. Control, June 1, 2004; 13(2): 206 - 206.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
T. G. Dinan
Introduction
The British Journal of Psychiatry, April 1, 2004; 184(47): s53 - s54.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
C. Bushe and R. Holt
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
The British Journal of Psychiatry, April 1, 2004; 184(47): s67 - s71.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. H. Thakore
Metabolic disturbance in first-episode schizophrenia
The British Journal of Psychiatry, April 1, 2004; 184(47): s76 - s79.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. Peet
Diet, diabetes and schizophrenia: review and hypothesis
The British Journal of Psychiatry, April 1, 2004; 184(47): s102 - s105.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
I. Cormac, D. Martin, and M. Ferriter
Improving the physical health of long-stay psychiatric in-patients
Advan. Psychiatr. Treat., March 1, 2004; 10(2): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Bull.Home page
M. Boilson and R. J. Hamilton
A survey of monitoring of weight and blood glucose in in-patients
Psychiatr. Bull., November 1, 2003; 27(11): 424 - 426.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. F. Brunette, R. E. Drake, B. J. Marsh, W. C. Torrey, S. D. Rosenberg, and the Five-Site Health and Risk Study Research Commi
Blood-Borne Infections and Persons With Mental Illness: Responding to Blood-Borne Infections Among Persons With Severe Mental Illness
Psychiatr Serv, June 1, 2003; 54(6): 860 - 865.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
O. Freudenreich and T. A. Stern
Clinical Experience With the Management of Schizophrenia in the General Hospital
Psychosomatics, February 1, 2003; 44(1): 12 - 23.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
R. G. McCREADIE
Use of drugs, alcohol and tobacco by people with schizophrenia: case--control study
The British Journal of Psychiatry, October 1, 2002; 181(4): 321 - 325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. M. Desai, R. A. Rosenheck, B. G. Druss, and J. B. Perlin
Mental Disorders and Quality of Diabetes Care in the Veterans Health Administration
Am J Psychiatry, September 1, 2002; 159(9): 1584 - 1590.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. Phelan, L. Stradins, and S. Morrison
Physical health of people with severe mental illness
BMJ, February 24, 2001; 322(7284): 443 - 444.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 2000 The Royal College of Psychiatrists.